enzyme

A team of international researchers developed an injectable drug that cuts the potential damage to the heart and brain tissues after an attack by a staggering 60 percent.

Lead author of the study, Professor Wilhelm Schwaeble, of Leicester University's department of Infection, Immunity and Inflammation stated, "This is a fascinating new achievement in the search for novel treatments to significantly reduce the tissue damage and impaired organ function that occur following ischaemia in widespread and serious conditions such as heart attacks and strokes.

Researchers have found that a key enzyme named 'Sirt3,' may help dramatically slow down the aging process in an individual.

Experts aver that under reduced calorie intake, the anti-aging enzyme level escalates in body which in turn prevents cellular damage and aging in long term.

Lead researcher, Tomas A. Prolla at the University of Wisconsin-Madison said, "We're getting closer and closer to a good understanding of how caloric restriction works.

“This study is the first direct proof for a mechanism underlying the anti-aging effects we observe under caloric restriction."

Researchers from University of Cincinnati, U.S., found that metformin could help cure certain cancers along with tuberous sclerosis complex (TSC)--multi-system genetic disease causing growth of mild tumors in the brain and other vital organs like kidneys, heart, eyes, lungs and skin.

According to study researchers, previous studies have provided evidence that people taking metformin seem to be guarded against certain types of cancers.

Details of the study